塞法索林:诱导凝血病的罕见病因
Ahmed Ismail1, Anam Habib2, Cayleigh Blumrick2
1Department of Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, USA.
Cureus
|February 23, 2026
概括
长期治疗梅西林敏感黄金葡萄球菌 (MSSA) 感染的塞法佐林,很少会导致严重的凝血病. 监测凝血是至关重要的,特别是在老年患者中,以检测和管理这种罕见的不良影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
背景情况:
- 塞法索林 (Cefazolin) 是第一代塞法洛斯波林,是MSSA感染的常见治疗方法.
- 虽然通常是安全的,但罕见的凝血异常与塞法林治疗有关.
研究的目的:
- 在接受长期塞法林治疗的老年患者中报告严重凝血病例.
- 为了强调在延长塞法林治疗期间监测凝血参数的重要性.
主要方法:
- 一个81岁的男性患者的病例报告.
- 详细描述临床表现,实验室发现和治疗过程.
- 监测国际规范化比率 (INR) 和激活部分血栓形成时间 (aPTT).
主要成果:
- 患者在开始服用塞法林后出现了严重的凝血病,INR和aPTT明显升高.
- 尽管停止了其他抗凝剂,但凝血异常仍然存在.
- 停止服用塞法林和维生素K导致凝血参数的快速改善和正常化.
结论:
- 塞法索林很少会引起显著的凝血病,呈现为高的INR和aPTT.
- 在长期治疗塞法林时,密切监测凝血是必不可少的,特别是在老年或高风险患者中.
- 及时识别和管理,包括维生素K的管理,可以逆转塞法林诱导的凝血病.
相关概念视频
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
11.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K
Extrinsic and Intrinsic Pathways of Hemostasis
13.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
231
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
231
Drug toxicity: Idiosyncratic Reactions
50
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
50


